Lygos, Inc.
BERKELEY, CA · Founded 2010 · CIK 0001518601 · Biotech · Private
Microbial catalyst strain engineered to convert plant sugars into high-value biochemical via biosynthetic pathway with CO2 sequestration
lygos.io →- Grants
- $2.4M
- 8 awards
- Sector median: 1
- Raised
- $41M
- 5 Form D · Apr 2019
- 90 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 13 granted · 27 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20102012201420162018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,280 | |
| Federal grant | Department of Agriculture · Microbial Production Of Polymer Precursors | $100,000 | |
| Federal grant | Department of Agriculture · Production Of Organic Acids From Crude Glycerol In Industrial Yeast Hosts | $100,000 | |
| Federal grant | Department of Agriculture · Product Recovery From Novel Fermentation Processes For Bio-manufacturing High-value Chemicals From Renewable Feedstocks | $450,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Large-scale, high-throughput optimization of gene expression in industrial yeast for improved small molecule production | $1,425,979 | |
| Federal grant | Department of Agriculture · Microbial Production Of A High-value Chemical From Lignocellusic Sugars | $100,000 | |
| Private capital raised | Form D · SEC | $1,176,739 | |
| Private capital raised | Form D · SEC | $13,463,148 | |
| Federal grant | Department of Energy · Phase I · Two-phase Production of an Organic Acid with CO2 Sequestration | $150,000 | |
| Federal grant | Department of Agriculture · Phosphatase Engineering For Microbial Production Of A High-value Organic Acid | $91,515 | |
| Private capital raised | Form D · SEC | $15,510,512 | |
| Private capital raised | Form D · SEC | $10,902,117 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2123 | Indapta Therapeutics Inc. | — | $84M |
| 2124 | PERIOMICS CARE LLC | — | — |
| 2125 | Apricity Therapeutics | — | — |
| 2126 | Lygos, Inc. | — | $41M |
| 2127 | SENSORIUM THERAPEUTICS INC | — | $39M |
| 2128 | CMTX BIOTECH INC | — | $500K |
| 2129 | ProMIS Neurosciences Inc. | — | $39M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jeffrey DietrichDirector · Executive Officer
- Jeffrey FortmanDirector · Executive Officer
- Brad GillespieDirector
- Leonard KatzDirector
- Jay KeaslingDirector
- Eric SteenDirector · Executive Officer
Patents
- Recombinant Host Cells And Methods For The Production Of Glycolic Acidapplication
- Recombinant Host Cells For The Production Of Malonategranted
- Compositions Comprising Renewable Polyaspartic Acid And Related Methodsgranted
- Recombinant Host Cells And Methods For The Production Of Glyceric Acid And Downstream Productsapplication
- Preparing Diesters Of Malonic Acidapplication
- Continuous Ion Exchange And Esterification Of Fermented Malonic Acidapplication
- Large Scale Production Of Divarin, Divarinic Acid And Other Alkyl Resorcinols By Fermentationapplication
- Fungal Cannabinoidsapplication
- Recombinant Host Cells And Methods For The Production Of Glyceric Acid And Downstream Productsgranted
- Cannabinoids From Substituted Resorcinol Carboxylic Acidsapplication
- Methods And Organisms For Producing Glycolic Acidapplication
- Advanced Production of Cannabinoids in Yeastgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.